IMPLANET SA EO 001
Implanet S.A., together with its subsidiaries, manufactures and sells implants and medical instruments for orthopedic surgery in France, the United States, Europe, the Middle East, Africa, and internationally. The company offers spinal and knee products, including Jazz PF, Jazz Evo, Jazz Cap SP, Jazz Passer, Jazz Lock, Jazz Claw, and Jazz Frame, as well as ISS-Jazz Screw systems for posterior fix… Read more
IMPLANET SA EO 001 (IM11) - Net Assets
Latest net assets as of : €- EUR
Based on the latest financial reports, IMPLANET SA EO 001 (IM11) has net assets worth €- EUR as of .
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€-) and total liabilities (€-). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €- |
| % of Total Assets | 0% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
IMPLANET SA EO 001 - Net Assets Trend (None–None)
This chart illustrates how IMPLANET SA EO 001's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for IMPLANET SA EO 001 (None–None)
The table below shows the annual net assets of IMPLANET SA EO 001 from None to None.
| Year | Net Assets | Change |
|---|---|---|
| No yearly data available. | ||
Equity Component Analysis
This analysis shows how different components contribute to IMPLANET SA EO 001's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- No equity composition insights available.
IMPLANET SA EO 001 Competitors by Market Cap
The table below lists competitors of IMPLANET SA EO 001 ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Supra Boga Lestari Tbk
JK:RANC
|
$6.84 Million |
|
Income Opportunity Realty Investors
NYSE MKT:IOR
|
$6.84 Million |
|
AI/ML Innovations Inc
OTCQB:AIMLF
|
$6.84 Million |
|
Naphtha
TA:NFTA
|
$6.84 Million |
|
Pcs Edventures Com
PINK:PCSV
|
$6.83 Million |
|
Indomobil Multi Jasa Tbk
JK:IMJS
|
$6.83 Million |
|
Green Technology Metals Limited
PINK:GTMLF
|
$6.83 Million |
|
PT Dafam Property Indonesia Tbk
JK:DFAM
|
$6.83 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in IMPLANET SA EO 001's equity between the two most recent reporting periods.
Insufficient data available to analyze equity growth attribution.
Book Value vs Market Value Analysis
This analysis compares IMPLANET SA EO 001's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Insufficient data available to analyze book value vs market value.
Capital Efficiency Dashboard
This dashboard shows how efficiently IMPLANET SA EO 001 utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Insufficient data available to analyze capital efficiency metrics.
Industry Comparison
This section compares IMPLANET SA EO 001's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $253,026,393
- Average return on equity (ROE) among peers: -74.55%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| IMPLANET SA EO 001 (IM11) | €- | N/A | N/A | $6.84 Million |
| HeraMED Limited (1I4) | $-105.98K | 0.00% | 0.00x | $17.10 Million |
| Q-linea AB (publ) (3F80) | $163.19 Million | -164.65% | 0.41x | $9.30 Million |
| Guerbet SA (4G8) | $342.14 Million | 13.51% | 1.79x | $42.41 Million |
| Scandinavian Real Heart AB (Publ) (7820) | $111.29 Million | -9.42% | 0.06x | $4.77 Million |
| aap Implantate AG (AAQ1) | $54.78 Million | 26.71% | 0.17x | $9.72 Million |
| Carmat SA (CXT) | $7.48 Million | -557.76% | 3.92x | $1.62 Million |
| elexxion AG (E8X) | $-0.01 | 0.00% | 0.00x | $199.10K |
| AETHLON MEDIC.NEW DL-001 (EJU) | $15.06 Million | -79.86% | 0.16x | $446.12K |
| Eckert & Ziegler Strahlen- und Medizintechnik AG (EUZ) | $139.44 Million | 15.79% | 0.97x | $620.14 Million |
| Gaush Meditech Ltd (F7Y) | $1.70 Billion | 10.23% | 0.68x | $29.29 Million |